|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.000551592
|
|
|
TCRG
|
[NCBI]
|
0.00054528
|
|
|
CD
|
[NCBI]
|
0.000240743
|
|
|
OCP
|
[NCBI]
|
0.000189848
|
|
|
TCRD
|
[NCBI]
|
0.000181207
|
|
|
alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity
|
[NCBI]
|
0.000153706
|
|
|
GCPS
|
[NCBI]
|
0.000153423
|
|
|
TNFSF6
|
[NCBI]
|
0.000122803
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.000102527
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
9.22342e-05
|
|
|
RORC
|
[NCBI]
|
8.7638e-05
|
|
|
MICA
|
[NCBI]
|
6.60231e-05
|
|
|
TNF
|
[NCBI]
|
6.35421e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
6.05546e-05
|
|
|
MICB
|
[NCBI]
|
5.73073e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
5.61144e-05
|
|
|
CD81
|
[NCBI]
|
5.58713e-05
|
|
|
FGF7
|
[NCBI]
|
5.41482e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.21646e-05
|
|
|
LAT
|
[NCBI]
|
5.12288e-05
|
|
|
CVID
|
[NCBI]
|
4.60963e-05
|
|
|
LCK
|
[NCBI]
|
4.5546e-05
|
|
|
KLRK1
|
[NCBI]
|
4.1748e-05
|
|
|
BCR
|
[NCBI]
|
3.90089e-05
|
|
|
JAK3
|
[NCBI]
|
3.24821e-05
|
|
|
t-cell antigen receptor, gamma subunit, alternate reading frame protein
|
[NCBI]
|
3.04508e-05
|
|
|
BCL11B
|
[NCBI]
|
3.04508e-05
|
|
|
BST1
|
[NCBI]
|
2.86339e-05
|
|
|
SOX13
|
[NCBI]
|
2.72835e-05
|
|
|
RPL22
|
[NCBI]
|
2.72835e-05
|
|
|
CCNG1
|
[NCBI]
|
2.6208e-05
|
|
|
TSN
|
[NCBI]
|
2.5314e-05
|
|
|
LTBR
|
[NCBI]
|
2.5314e-05
|
|
|
LCP2
|
[NCBI]
|
2.5314e-05
|
|
|
WBSCR5
|
[NCBI]
|
2.45491e-05
|
|
|
tl antigen
|
[NCBI]
|
2.45491e-05
|
|
|
CD3D
|
[NCBI]
|
2.38806e-05
|
|
|
CEBPE
|
[NCBI]
|
2.32871e-05
|
|
|
CD3E
|
[NCBI]
|
2.27534e-05
|
|
|
TLX1
|
[NCBI]
|
2.27534e-05
|
|
|
SMARCA4
|
[NCBI]
|
2.22686e-05
|
|
|
CHS
|
[NCBI]
|
2.2097e-05
|
|
|
IL2
|
[NCBI]
|
2.20033e-05
|
|
|
RBPSUH
|
[NCBI]
|
2.18245e-05
|
|
|
ZAP70
|
[NCBI]
|
2.14149e-05
|
|
|
INDO
|
[NCBI]
|
2.14149e-05
|
|
|
NCF1
|
[NCBI]
|
2.00354e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.00354e-05
|
|
|
IL15
|
[NCBI]
|
1.97405e-05
|
|
|
IL7R
|
[NCBI]
|
1.97405e-05
|
|
|
CCL25
|
[NCBI]
|
1.89436e-05
|
|
|
CREB1
|
[NCBI]
|
1.76415e-05
|
|
|
TNFSF8
|
[NCBI]
|
1.6925e-05
|
|
|
MG
|
[NCBI]
|
1.63128e-05
|
|
|
IKBKG
|
[NCBI]
|
1.62955e-05
|
|
|
EGF
|
[NCBI]
|
1.61565e-05
|
|
|
RAG1
|
[NCBI]
|
1.61494e-05
|
|
|
TCRA
|
[NCBI]
|
1.52286e-05
|
|
|
PRF1
|
[NCBI]
|
1.44484e-05
|
|
|
VEGF
|
[NCBI]
|
1.43494e-05
|
|
|
NOTCH1
|
[NCBI]
|
1.28641e-05
|
|
|
TLR3
|
[NCBI]
|
1.22273e-05
|
|
|
IL10
|
[NCBI]
|
1.19685e-05
|
|
|
WAS
|
[NCBI]
|
1.10395e-05
|
|
|
PRLR
|
[NCBI]
|
1.06508e-05
|
|
|
MAOA
|
[NCBI]
|
1.01492e-05
|
|
|
MBP
|
[NCBI]
|
9.91977e-06
|
|
|
TLR9
|
[NCBI]
|
9.65644e-06
|
|
|
LEP
|
[NCBI]
|
8.52104e-06
|
|
|
EPOR
|
[NCBI]
|
7.41968e-06
|
|
|
TLR2
|
[NCBI]
|
6.10358e-06
|
|
|
ADA
|
[NCBI]
|
4.65227e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.00563e-06
|
|
|
CTGF
|
[NCBI]
|
2.85561e-06
|
|
|
KLK3
|
[NCBI]
|
1.9035e-06
|
|
|
SLE
|
[NCBI]
|
1.28089e-06
|
|
|
AHR
|
[NCBI]
|
1.10239e-06
|
|
|
RNASE3
|
[NCBI]
|
1.09956e-06
|
|
|
SPP1
|
[NCBI]
|
9.87978e-07
|
|
|
MPO
|
[NCBI]
|
3.75429e-07
|
|
|
HGF
|
[NCBI]
|
2.28424e-07
|
|
|
PRL
|
[NCBI]
|
6.73653e-08
|
|
|
PCNA
|
[NCBI]
|
1.52182e-08
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.1484e-08
|
|